User profiles for Imran S Haque

Imran S Haque

Recursion Pharmaceuticals
Verified email at cs.stanford.edu
Cited by 6308

Current and future perspectives of liquid biopsies in genomics-driven oncology

E Heitzer, IS Haque, CES Roberts… - Nature Reviews …, 2019 - nature.com
Precision oncology seeks to leverage molecular information about cancer to improve patient
outcomes. Tissue biopsy samples are widely used to characterize tumours but are limited …

MSMBuilder2: modeling conformational dynamics on the picosecond to millisecond scale

…, TJ Lane, L Maibaum, IS Haque… - Journal of chemical …, 2011 - ACS Publications
Markov state models provide a framework for understanding the fundamental states and
rates in the conformational dynamics of biomolecules. We describe an improved protocol for …

[HTML][HTML] An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals

GA Lazarin, IS Haque, S Nazareth, K Iori… - Genetics in …, 2013 - nature.com
Purpose: Recent developments in genomics have led to expanded carrier screening panels
capable of assessing hundreds of causal mutations for genetic disease. This new …

Modeled fetal risk of genetic diseases identified by expanded carrier screening

IS Haque, GA Lazarin, HP Kang, EA Evans… - Jama, 2016 - jamanetwork.com
Importance Screening for carrier status of a limited number of single-gene conditions is the
current standard of prenatal care. Methods have become available allowing rapid expanded …

[HTML][HTML] Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA

…, C Tang, A Tzou, L Young, G Putcha, IS Haque - BMC cancer, 2019 - Springer
Background Blood-based methods using cell-free DNA (cfDNA) are under development as
an alternative to existing screening tests. However, early-stage detection of cancer using …

Hard data on soft errors: A large-scale assessment of real-world error rates in gpgpu

IS Haque, VS Pande - … Conference on Cluster, Cloud and Grid …, 2010 - ieeexplore.ieee.org
Graphics processing units (GPUs) are gaining widespread use in high-performance computing
because of their performance advantages relative to CPUs. However, the reliability of …

[HTML][HTML] Systematic classification of disease severity for evaluation of expanded carrier screening panels

…, NS Collins, EA Platt, EA Evans, IS Haque - PloS one, 2014 - journals.plos.org
Professional guidelines dictate that disease severity is a key criterion for carrier screening.
Expanded carrier screening, which tests for hundreds to thousands of mutations …

Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2

…, BA Earnshaw, ML Victors, YT Chong, IS Haque… - BioRxiv, 2020 - biorxiv.org
To identify potential therapeutic stop-gaps for SARS-CoV-2, we evaluated a library of 1,670
approved and reference compounds in an unbiased, cellular image-based screen for their …

[HTML][HTML] Expanded carrier screening: a review of early implementation and literature

GA Lazarin, IS Haque - Seminars in perinatology, 2016 - Elsevier
Carrier screening is the practice of testing individuals to identify those at increased risks of
having children affected by genetic diseases. Professional guidelines on carrier screening …

Clinical utility of expanded carrier screening: reproductive behaviors of at‐risk couples

CE Ghiossi, JD Goldberg, IS Haque… - Journal of genetic …, 2018 - Wiley Online Library
Expanded carrier screening (ECS) analyzes dozens or hundreds of recessive genes to
determine reproductive risk. Data on the clinical utility of screening conditions beyond …